
VedaBio
VedaBio is a YC Summer 2021 (S21) company. Based in San Diego, CA, USA; Urbana, IL, USA. Team of 30.
About VedaBio
Summary
VedaBio builds CRISPR-based molecular diagnostic tests for urgent care, delivering syndromic respiratory panel results in under ten minutes at the point of care. The system pairs a benchtop instrument with a single-use cartridge and requires no laboratory or trained operator, running at the molecular accuracy level without target amplification. It replaces the current workflow where most urgent-care respiratory patients leave without a definitive diagnosis and are treated on incomplete information.
Go-to-market
Urgent care centers are the target customer, with a point-of-care instrument and cartridge designed to slot into existing clinic workflows without lab infrastructure or specialist training.
From the Y Combinator listing
CRISPR powered Diagnostics with results in minutes.
Syndromic testing powered by engineered CRISPR enzymes. Get comprehensive results in every doctor visit. More at www.vedabio.com
Facts
- Healthcare / Healthcare -> Diagnostics
- San Diego, CA, USA; Urbana, IL, USA
- 30
- Active
- Early
Founders (1)
- Anurup Ganguli
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works